• ABOUT US
    • History
    • Our Team
    • Advertising
    • Subscription
  • CONTACT US
Georgia Today
No Result
View All Result
  • News
  • Politics
  • Business & Economy
  • Social & Society
  • Sports
  • Culture
  • News
  • Politics
  • Business & Economy
  • Social & Society
  • Sports
  • Culture
No Result
View All Result
Georgia Today
No Result
View All Result

EU-Supported Innovative Georgian Pharmacompany Opens a New Manufacturing Facility

by Georgia Today
February 27, 2023
in Business & Economy, Magazine
Reading Time: 3 mins read
The newly modernized plant of BioChimPharm is located in Tbilisi represents the first enterprise producing sterile liquid dosage forms in the South Caucasus, covering the full production cycle, including the production of active pharmaceutical ingredients

The newly modernized plant of BioChimPharm is located in Tbilisi represents the first enterprise producing sterile liquid dosage forms in the South Caucasus, covering the full production cycle, including the production of active pharmaceutical ingredients

The Georgian biopharmaceutical company BioChimPharm (BCP) has completed the process of modernization of its historic Bacteriophage (Phage) manufacturing factory. A two-year investment project worth GEL 17.5 million (€ 6,000,000) has been implemented with the support of the EU, the EBRD, FAO and the Ministry of Economy and Sustainable Development of Georgia.

As a result, BioChimPharm reequipped the plant in compliance with the EU GMP (Good Manufacturing Practice) guidelines, an accepted standard in the European Union and the Company plans applying for GMP certification within the following months.

“Congratulations to the new production facilities!” stated Ambassador Pawel Herczycnski during his visit there. “They will enable BioChimPharm to produce pharmaceutical products in compliance with Good Manufacturing Practices (GMP), an accepted standard in the European Union. We hope that this success will be an inspiration for other companies to scale up knowledge-intensive and high value-added production in Georgia.”

“We are glad that the enterprise operates successfully and continues the very long tradition that the country has in the production of bacteriophages,” said Minister of Economy and Sustainable Development of Georgia, Levan Davitashvili. “This enterprise, Georgia, will be proudly represented on the map of technologies, including biotechnologies, in the future.”

“The production of phage preparations and the phage therapy are still a novelty for most countries. Millions of people still do not have access to phages, leaving patients vulnerable to antibiotic-resistant infections,” said Rati Golijashvil, the general manager of BioChimPharm. “With this project, our company is increasing its production capacity and export area, thus making phages available for millions of patients around the globe. The modernization of the manufacturing plant, high-tech infrastructure and production lines enables us to scale-up production in compliance with internationally recognized manufacturing standards, to become more effective in the fight against the resistant infections and to overcome the global threat of antibiotic resistance.”

The opening event of the first industrial scale manufacturing plant of phage preparations that meets sterile (aseptic) production guidelines was attended by Levan Davitashvili, Minister of Economy and Sustainable Development of Georgia; Pawel Herczynski, Ambassador of the European Union to Georgia; Catarina Bjorlin Hansen, EBRD Regional Director for the Caucasus; and Javier Sanz Alvarez, Coordinator of FAO projects in Georgia.

About BioChimPharm and EU Support
The newly modernized plant of BioChimPharm is located in Tbilisi, in the historic Bacteriophage Institute, and represents the first enterprise producing sterile liquid dosage forms in the South Caucasus, covering the full production cycle, including the production of active pharmaceutical ingredients (APIs, substance), as well as primary and secondary packaging of medicines.

The company has completed a two-year investment project worth GEL 17.5 million (€ 6,000,000) with the support of the EU, the EBRD and the Ministry of Economy and Sustainable Development of Georgia. The company received support under two EU programs. The EBRD provided a loan through Procredit Bank, its partner financial institution with the goal to bring production in line with an international standard (GMP – good manufacturing practice) which is compulsory for accessing EU and other international markets.

The EU is complementing the EBRD financing with a cash back grant under the flagship EU4Business-EBRD Credit Line.

The EU and FAO awarded a matching grant of €125,000. The grant is aimed at supporting “PowerPhage” production, a phage based, natural antimicrobial veterinary solution, which substitutes antibiotics in animal agriculture and reduces the use of antibiotics in meat production, with a focus on poultry farms. The matching grant is a part of a total investment, aimed to allow a 300% increase in “PowerPhage” production. The latter contribution was allocated on upgrading the manufacturing line to ensure EU good manufacturing practice compliance.

BioChimPharm is a Georgian based biopharmaceutical company producing bacteriophage (phage) preparations. Currently, phage medicines are the only viable alternative to antibiotics. BioChimPharm exports phages to 8 countries, employees a team of 60 people, holds 2 international patents and boasts nearly 100 years of experience in phage R&D and production.

Tags: bacteriophage (phage)BioChimPharm is a Georgian pharmaceutics
ShareShareTweet

Related Posts

Source: getaboutasia.com
Newspaper

War in Ukraine and Kazakhstan’s Multi-Vector Foreign Policy

March 30, 2023
‘Green Diamond’ – All Attributes of Comfort in One, Ecologically Clean and Green Space
Newspaper

‘Green Diamond’ – All Attributes of Comfort in One, Ecologically Clean and Green Space

March 30, 2023
GAA Holding – The International Success Story of a 30-Year-Old Georgian Company
Newspaper

GAA Holding – The International Success Story of a 30-Year-Old Georgian Company

March 30, 2023

Recommended

Georgian Foreign Minister Holds Farewell Meeting with French Ambassador to Georgia

Georgian Foreign Minister Holds Farewell Meeting with French Ambassador to Georgia

6 months ago
Natia Mezvrishvili on Dealing with 2 Political Giants

Natia Mezvrishvili on Dealing with 2 Political Giants

12 months ago
Giorgi Gakharia: We were Told We Were Capable of Nothing – It’s All a Lie and Ukraine is a Great Example of This

Giorgi Gakharia: We were Told We Were Capable of Nothing – It’s All a Lie and Ukraine is a Great Example of This

1 year ago
GT Interview with Giorgi Badridze

GT Interview with Giorgi Badridze

1 year ago
Russo-Ukrainian War and Georgia – Analysis from security expert Kakha Kemoklidze

Russo-Ukrainian War and Georgia – Analysis from security expert Kakha Kemoklidze

1 year ago

Navigation

  • News
  • Politics
  • Business & Economy
  • Social & Society
  • Sports
  • Culture
  • International
  • Where.ge
  • Newspaper
  • Magazine
  • GEO
  • OP-ED
  • About Us
    • History
    • Our Team
    • Advertising
    • Subscription
  • Contact

Highlights

President to GD: You are a gov’t that opposes the foreign goal of the country

Art gallery of the famous artist Rusudan Petviashvili to open in Tbilisi

Tbilisi Open Air line-up announced

One killed, three injured by strong wind in Georgia’s Adjara region

UNM faction to resume parliamentary activities

Amnesty International report highlights restricted freedom of expression, selective justice in Georgia

Trending

No Content Available
  • Where.ge
  • Newspaper
  • GEO
  • Magazine
  • Old Website

2000-2022 © Georgia Today

No Result
View All Result
  • News
  • Politics
  • Business & Economy
  • Social & Society
  • Sports
  • Culture
  • International
  • Where.ge
  • Newspaper
  • Magazine
  • GEO
  • OP-ED
  • About Us
    • History
    • Our Team
    • Advertising
    • Subscription
  • Contact

2000-2022 © Georgia Today